Dezhan health started to produce hemp raw materials at this time? What's the meaning?

On November 19, Dezhan health released the public announcement on the signing of equity transfer agreement and foreign investment by the company to acquire 20% equity of Yunnan Suma Biotechnology Co., Ltd (hereinafter referred to as "Suma biotechnology") held by Hamma investment, with a transaction price of RMB 100 million As an industrial hemp leaf production and sales company, hemp bio has a leading level of Industrial Hemp Variety cultivation technology, an industrial hemp planting base complying with gap standards, and a flower leaf processing enterprise with industrialization standards As the source enterprise of the industrial hemp industry chain, hemp bio is the core node of the industrial hemp industry chain This foreign investment is to implement the company's development strategy, lay out the business of industrial hemp seed cultivation, planting, etc., and realize the stable source of raw materials in the field of industrial hemp application Just the day before yesterday, Kangenbei also issued two consecutive announcements, which clearly revealed that the company has officially obtained the industrial hemp processing license, and in order to ensure Yunnan Yunxing company has a relatively sufficient supply of industrial hemp leaves raw materials, in 2019, Yunnan Yunxing company plans to purchase a total amount of 3 from ximekang company, Luxi Xikang company and xinuokang biotechnology company, 5.2 million yuan (including tax) of industrial hemp leaves In addition, Kangenbei clearly pointed out in the announcement that there are risks in the processing of industrial marijuana: 1 Uncertainty risks such as changes in relevant regulations, rules and regulatory policies of industrial marijuana 2 External macro environment and market demand change and uncertainty risks such as the time to obtain customer orders and order size 3 Uncertain risks such as whether production, technology and management can meet the quality and scale requirements of customers and product supply 4 The company's own production, operation and management and other factors bring uncertainty risks In addition, considering the fact that the stock market did not increase but decreased after the announcement of Kangenbei, there are also several major problems existing in the domestic industrial cannabis industry chain, It is very likely to overturn the view that the industry chain is now in good agreement The drug Zhi net will thoroughly analyze the deep connotation of the connba industrial hemp industry in today's WeChat official account and scan the bottom code for the first time Penicillin statement: this opinion only represents the author, not the position of yaozhi.com, welcome to exchange and supplement in the message area; if you need to reprint, please be sure to indicate the author and source of the article.